Answers are grounded in this paper and cite their sources.
Hepatocellular carcinoma affects only a subset of patients with chronic liver disease, suggesting that additional mutagenic and microenvironmental stressors influence cancer risk. In this review, we explore the gut–liver axis as a contributor to this heterogeneity. We propose a model in which direct microbial genotoxins, microbiota-derived genotoxic metabolites, and dysbiosis-associated oxidative stress may contribute to hepatocyte DNA damage. In parallel, microbial metabolites and structural immune stimuli may modulate hepatic stellate cell states and tumor-promoting inflammation. The deoxycholic acid–hepatic stellate cell senescence axis is supported in experimental obesity-associated liver cancer, whereas colibactin-specific hepatic mutagenesis, microbiota-derived acetaldehyde-induced DNA damage and hydrogen sulfide-dependent stromal reprogramming remain unproven in hepatocellular carcinoma. Collectively, these mechanisms could couple hepatocyte genomic diversification with microenvironmental selection. In conclusion, whether this proposed interplay contributes to human hepatocarcinogenesis remains to be established.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: